The physicochemical properties of the novel original anxiolytic GML-1 drug substance were studied, analytical techniques for it were developed, and its main pharmacopoeial quality parameters were determined using IR spectroscopy, UV spectrophotometry, HPLC, and the Kjeldahl method.
Similar content being viewed by others
References
S. A. Yarkov, G. V. Mokrov, T. A. Gudasheva, et al., Eksp. Klin. Farmakol., 79(1), 7 – 11 (2016).
S. B. Seredenin, G. V. Mokrov, T. A. Gudasheva, et al., RU Pat. No. 2,572,076, Dec. 27, 2015, “1-Arylpyrrolo[1,2-a]pyrazine-3-carboxamides with neuropsychotropic activity.”
G. V. Mokrov, O. A. Deeva, T. A. Gudasheva, et al., Bioorg. Med. Chem., 23(13), 3368 – 3378 (2015).
M. A. Yarkova, P. Yu. Povarnina, G. Mokrov, et al., Eksp. Klin. Farmakol., 80(4), 3 – 7 (2017).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 9, pp. 43 – 48, September, 2018.
Rights and permissions
About this article
Cite this article
Gaevaya, L.M., Grushevskaya, L.N., Sergeeva, M.S. et al. Physicochemical Properties and Analytical Method Development for Drug Substance of GML-1, a Novel Original Anxiolytic Preparation. Pharm Chem J 52, 790–795 (2018). https://doi.org/10.1007/s11094-018-1901-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1901-7